ABILIFY
Live / Registered — Registered and renewed (as of 06 Feb 2024)
What this means for you
Registered since 07 Oct 2003. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 07 Oct 2023).
Record
- Serial number
- 78135340
- Registration number
- 2772697
- Mark type
- Word mark
- Filed
- 13 Jun 2002
- Published for opposition
- 24 Dec 2002
- Registered
- 07 Oct 2003
- Next maintenance due
- 07 Oct 2023
- Attorney of record
- Scott S. Havlick
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment [ and prevention ] of [ cardiovascular diseases, ] central nervous system diseases [ and disorders ] [, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, antibiotics ]
Owner
- OTSUKA PHARMACEUTICAL CO., LTD., TOKYO, JP
- Bristol-Myers Squibb Company, New York, NY, US
- Bristol-Myers Squibb Company, New York, NY, US
- Bristol-Myers Squibb Company, New York, NY, US
Prosecution history
- 06 Feb 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 06 Feb 2024 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 06 Feb 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 06 Feb 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Aug 2023 — TEAS SECTION 8 & 9 RECEIVED
- 07 Oct 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 02 Aug 2013 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 02 Aug 2013 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 02 Aug 2013 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 02 Aug 2013 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 19 Jul 2013 — TEAS SECTION 8 & 9 RECEIVED
- 18 Nov 2008 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 04 Nov 2008 — ASSIGNED TO PARALEGAL
- 24 Oct 2008 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
- 24 Oct 2008 — PAPER RECEIVED